The Current Ratio as of November 2024 (TTM) for Atea Pharmaceuticals, Inc. (AVIR) is 19.33

According to Atea Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 19.33. This represents a change of 10.65% compared to the average of 17.47 of the last 4 quarters.

Atea Pharmaceuticals, Inc. (AVIR) Historical Current Ratio (quarterly & annually)

How has AVIR Current Ratio performed in the past?

The mean historical Current Ratio of Atea Pharmaceuticals, Inc. over the last ten years is 16.51. The current 19.33 Current Ratio has changed 11.61% with respect to the historical average. Over the past ten years (40 quarters), AVIR's Current Ratio was at its highest in in the March 2023 quarter at 51.16. The Current Ratio was at its lowest in in the March 2019 quarter at 0.

Atea Pharmaceuticals, Inc. (AVIR) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Atea Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Atea Pharmaceuticals, Inc. (AVIR) Average Current Ratio

How has AVIR Current Ratio performed in the past?

The current Current Ratio of Atea Pharmaceuticals, Inc. (AVIR) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Atea Pharmaceuticals, Inc. (AVIR) Current Ratio vs. Peers

How is AVIR’s Current Ratio compared to its peers?

Atea Pharmaceuticals, Inc.’s Current Ratio is greater than Immix Biopharma, Inc. (3.47), greater than CNS Pharmaceuticals, Inc. (1.82), greater than Hepion Pharmaceuticals, Inc. (1.30), greater than Freeline Therapeutics Holdings plc (1.95), less than AVROBIO, Inc. (26.17), greater than Enveric Biosciences, Inc. (5.17), greater than CohBar, Inc. (15.69), greater than Elevation Oncology, Inc. (17.77), greater than Ocean Biomedical, Inc. (0.03), greater than eFFECTOR Therapeutics, Inc. (1.03),

Build a custom stock screener for Atea Pharmaceuticals, Inc. (AVIR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Atea Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Atea Pharmaceuticals, Inc. (AVIR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Atea Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.